Evaluation of 15(S) 15-methyl-PGF 2 alpha-methyl ester vaginal suppositories for cervical dilatation and second trimester pregnancy termination.
D000028:Abortion, Induced; D002584:Cervix Uteri / Q000187:drug effects*; D003967:Diarrhea / Q000139:chemically induced; D004107:Dilatation and Curettage / Q000295:instrumentation; D005260:Female; D006801:Humans; D011247:Pregnancy; D011261:Pregnancy Trimester, First; D011262:Pregnancy Trimester, Second; D011460:Prostaglandins F / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D013488:Suppositories; D014621:Vagina / Q000187:drug effects; D014839:Vomiting / Q000139:chemically induced
D011460:Prostaglandins F; D013488:Suppositories